4 free views remaining today
retinitis pigmentosa 49
ICD-10 Codes
Related ICD-10:
Description
Retinitis Pigmentosa (RP): A Group of Genetic Disorders
Retinitis pigmentosa is a group of genetic disorders that affect the retina's ability to respond to light, causing a slow loss of vision [1]. This condition is characterized by progressive deterioration of the retina, leading to visual problems and eventual blindness [8].
Key Features:
- Inherited: Retinitis pigmentosa is an inherited eye disease, meaning it is passed down from parents to their children through genes [2].
- Visual Problems: The condition causes a slow decline in eyesight, with early symptoms including trouble with night vision and irregular retina pigmentation [3][4].
- Progressive Vision Loss: Retinitis pigmentosa leads to progressive loss of night and peripheral vision, often resulting in complete blindness [7].
Causes and Risk Factors:
- Genetic Mutations: The condition is caused by genetic mutations that affect the retina's ability to respond to light.
- Inheritance Pattern: Retinitis pigmentosa is inherited in an autosomal recessive pattern, meaning a person must inherit two copies of the mutated gene (one from each parent) to develop the condition.
References:
[1] Context result 1 [2] Context result 2 [3] Context result 3 [4] Context result 4 [5] Context result 6 [7] Context result 7 [8] Context result 8
Additional Characteristics
- Retinitis pigmentosa
- complete blindness
- progressive deterioration of the retina
- slow decline in eyesight
- trouble with night vision and irregular retina pigmentation
- progressive loss of night and peripheral vision
- visual problems
- eventual blindness
- inherited eye disease
Signs and Symptoms
Common Signs and Symptoms of Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a group of rare, genetic disorders that affect the retina's ability to respond to light. The symptoms of RP can vary in severity and progression, but here are some common signs and symptoms:
- Night blindness: This is often the first sign of RP, where individuals have difficulty seeing in low-light conditions or at night [1][2].
- Gradual loss of peripheral vision: As the disease progresses, people with RP may experience a gradual narrowing of their field of vision, leading to tunnel vision [3][4].
- Reduced ability to see objects in shadows: Individuals with RP may have difficulty seeing objects or people in dimly lit areas or in shadows [5].
- Blind spots in peripheral (side) vision: Some people with RP may experience blind spots in their peripheral vision, which can be a sign of the disease's progression [1].
Other possible symptoms
In addition to these common signs and symptoms, some individuals with RP may also experience:
- Narrowing of retinal arterioles
- Cystoid macular edema
- Waxy yellow appearance of the disk
- Posterior subcapsular cataracts
- Cystic macular lesions
It's essential to note that these symptoms can vary in severity and progression, and not everyone with RP will experience all of them. If you or someone you know is experiencing any of these symptoms, it's crucial to consult a healthcare professional for proper diagnosis and treatment.
References: [1] - Context result 1 [2] - Context result 4 [3] - Context result 6 [4] - Context result 7 [5] - Context result 3
Additional Symptoms
- Night blindness
- Blind spots in peripheral (side) vision
- Gradual loss of peripheral vision
- Posterior subcapsular cataracts
- Waxy yellow appearance of the disk
- Cystic macular lesions
- Narrowing of retinal arterioles
- Reduced ability to see objects in shadows
- edema
Diagnostic Tests
Diagnostic Tests for Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a group of inherited eye diseases that affect the retina, and diagnosing it requires a combination of clinical evaluation and specialized tests. Here are some diagnostic tests used to diagnose RP:
- Electroretinography (ERG): This test measures the electrical activity of the retina in response to light stimulation. It's considered the most critical diagnostic test for RP, as it provides an objective measure of rod and cone function across the retina [7]. ERG can help confirm the diagnosis by demonstrating attenuated rod and cone signals [14].
- Optical Coherence Tomography (OCT): This imaging test takes highly detailed pictures of the retina, which can help diagnose RP and monitor its progression. OCT can show loss of photoreceptors at the optical coherence tomography scan [9].
- Visual Field Testing: This test helps measure side vision and find any blind spots that may be developing. It's useful in monitoring the progression of disease and documenting the status of legal blindness [4].
- Fundus Autofluorescence (FAF) Imaging: This test uses blue light to take a picture of the retina, which can show specific changes that suggest RP.
- Electrooculogram (EOG): This measurement tests the standing potential between the eyes and can help confirm the diagnosis.
These diagnostic tests are used in combination with clinical evaluation by an eye doctor to establish a diagnosis of retinitis pigmentosa.
Additional Diagnostic Tests
- Optical Coherence Tomography (OCT)
- Electroretinography (ERG)
- Electrooculogram (EOG)
- Visual Field Testing
- Fundus Autofluorescence (FAF) Imaging
Treatment
Current Drug Treatments for Retinitis Pigmentosa
While there are no definitive cures for retinitis pigmentosa (RP), various drug treatments have shown promise in slowing down the progression of the disease or improving visual function. Here are some of the current drug treatments being explored:
- Gene therapies: Gene therapy products like Luxturna (voretigene neparvovec) have been approved by the FDA to treat a specific type of RP caused by mutations in the RPE65 gene [1]. This treatment involves injecting a healthy copy of the gene into the retina.
- Oral acetazolamide: Studies have shown that oral acetazolamide, a carbonic anhydrase inhibitor, can improve visual function in some patients with RP [2].
- N-acetylcysteine (NAC): A Phase 3 clinical trial is currently underway at Johns Hopkins University to investigate the use of NAC for treating RP [3].
Emerging Therapies
Researchers are also exploring other potential treatments, including:
- Retinal gene therapies: These aim to target the underlying genetic cause of RP and offer a cure for some patients [4].
- Nanobodies: A recent discovery by UC Irvine researchers has led to the development of a nanobody that may lead to treatment for RP [5].
Important Note
It's essential to note that these treatments are still in various stages of research, and more studies are needed to confirm their efficacy and safety. If you're considering any of these treatments, consult with your healthcare provider or a specialist in retinal diseases.
References:
[1] Context result 6 [2] Context result 5 [3] Context result 7 [4] Context result 4 [5] Context result 8
Recommended Medications
- N-acetylcysteine (NAC)
- Luxturna (voretigene neparvovec)
- Nanobodies
- Retinal gene therapies
- Oral acetazolamide
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a complex group of inherited dystrophies, and its differential diagnosis can be extensive. Here are some conditions that may be considered in the differential diagnosis of RP:
- Leber's Congenital Amaurosis (LCA): This is a rare, inherited form of blindness that affects children and young adults. It is characterized by severe visual impairment or blindness from birth.
- Myotonic Dystrophy-Associated Retinopathy: This is a condition associated with myotonic dystrophy, a genetic disorder that affects muscle tone and can cause retinal degeneration.
- Syphilis: In rare cases, syphilis can cause retinal damage and be mistaken for RP.
- Congenital Rubella: This viral infection can cause visual impairment or blindness in children and may be considered in the differential diagnosis of RP.
- Chloroquine-Induced Retinopathy: Long-term use of chloroquine, an antimalarial medication, can cause retinal damage and be mistaken for RP.
- Other Retinal Degenerations: Various other conditions, such as cone-rod dystrophy, Stargardt disease, and Best vitelliform macular dystrophy, may also be considered in the differential diagnosis of RP.
Key Points to Consider
When considering the differential diagnosis of RP, it is essential to note that individuals with initial symptoms of photopsia (sensation of lights flashing), abnormal central vision, abnormal color vision, or marked asymmetry in ocular involvement may not have RP but another retinal degeneration or retinal disease.
References
- [4] Retinitis pigmentosa (RP) is an inherited retinal dystrophy caused by the loss of photoreceptors and characterized by retinal pigment deposits visible on fundus examination.
- [12] Retinitis pigmentosa (RP) is an inherited retinal dystrophy caused by the loss of photoreceptors and characterized by retinal pigment deposits visible on fundus examination.
- [13] The list of differential diagnoses in RP is extensive and includes infectious (e.g., syphilis or congenital rubella), drug-induced (e.g., chloroquine or ... Different stimuli are used to establish the diagnosis of retinitis pigmentosa, which is based on the guidelines of the International Society for Clinical Electrophysiology of Vision (ISCEV)
- [11] Differential Diagnosis of Nonsyndromic Retinitis Pigmentosa. It should be noted that individuals who present with initial symptoms of photopsia (sensation of lights flashing), abnormal central vision, abnormal color vision, or marked asymmetry in ocular involvement may not have RP, but another retinal degeneration or retinal disease.
Note: The numbers in square brackets refer to the search results provided.
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_4731
- owl#annotatedSource
- t366160
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#hasDbXref
- MIM:613756
- oboInOwl#id
- DOID:0110377
- core#notation
- DOID:0110377
- IAO_0000115
- A retinitis pigmentosa that has_material_basis_in mutation in the CNGA1 gene on chromosome 4p12.
- rdf-schema#label
- retinitis pigmentosa 49
- oboInOwl#hasExactSynonym
- RP49
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_10584
- relatedICD
- http://example.org/icd10/H35.5
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.